RNAZ

TRANSCODE THERAPEUTICS INC

RNAZ·89357L501·US·Common Stock·Healthcare - Biotechnology-Activist

RNAZ (TRANSCODE THERAPEUTICS INC) is held by 6 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($40,644), VANGUARD FIDUCIARY TRUST CO ($18,518), UBS Group AG ($17,934). Net institutional sentiment: Mixed.

6
Holders
$91,354
Total Value
40% (5)
Consensus
2 buying - 3 selling
13F: Insider & Congress: Updated regularly
RNAZ

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Sep 21, 2026 · Insiders none · Activists Aug 3, 2026 · Congress none

ActivistDEDEFJ, LLC83.9%Aug 3, 2026
ActivistERElena Rosa Braci6.2%Jul 28, 2026
ActivistDEDaniel Eduardo Katzman5.2%Jul 28, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
6,545$40,6440.0%-84.39%
0
Unchanged
2,982$18,5180.0%-84.39%
0
Decreased
2,888(-65.2%)$17,9340.0%-82.00%
0
New
706$4,3840.0%-74.24%
22
Unchanged
55$3420.0%-84.39%
0
Exited
0(-100.0%)$109,6900.0%-39.41%
0
Exited
0(-100.0%)$00.0%-54.74%
0
RNAZRNAZTRANSCODE THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used